High density lipoprotein cholesterol (HDL)
| Category | Biochemistry |
|---|---|
| Test background |
The fasting lipid profile assesses total cholesterol, total triglycerides and high density lipoprotein cholesterol. From these, low density lipoprotein cholesterol may be calculated. |
| Clinical Indications |
Family history of cardiovascular or other thrombotic events Diagnosis and monitoring of hyperlipidaemia Monitoring of high-risk groups, eg. hypertensive, obese, diabetics, etc. |
| Reference range | Male: >1 mmol/L
Female: >1.2 mmol/L
|
| Sample & container required | SST (gold top) |
| Sample volume | 0.5 mL |
| Turnaround time | 1 day |
| Notes | Non-HDL cholesterol (total chol minus HDL chol) is recommended for CVD risk prediction; fasting samples are not required for this. Non-HDL cholesterol targets for patients treated for CVD risk reduction are 40 % reduction from baseline (NICE CG181, 2014) or <2.5 mmol/L (JBS3. Heart 2014;100:ii1) The JBS3 CVD risk estimator is at http://www.jbs3risk.com/JBS3Risk.swf |